Zuber Lawler has been representing leading cannabis companies for 14 years handling initial public offerings (IPOs), M&As, finance, intellectual property, FDA and other regulatory work and litigation, in addition to representing a long list of iconic Fortune 500 companies, global funds and governmental entities in their international transactions.
Despite the country’s change in administration and widespread talk of federal legalization, the cannabis industry is complex. However, Zuber Lawler provides trusted and reliable legal representation to mitigate the complexity.
Well Decorated
Zuber Lawler’s accomplishments are many. The firm was recently named “Cannabis Law Firm of the Year” by Marijuana Venture Magazine and it obtained the second-ever-issued U.S. plant patent for a cannabis strain as well as U.S. utility patents on cannabis processes, machines and formulations. In addition, the firm obtained the first-ever issued “Generally Recognized as Safe” designati
Share this article
Share this article
PHOENIX, Feb. 17, 2021 /PRNewswire/ Item 9 Labs Corp. (OTCQX: INLB) ( Item 9 Labs or the Company ), a vertically integrated cannabis operator that produces premium products, today announced that Andrew Bowden, CEO of Item 9 Labs, will present live to an online audience at the Benzinga Cannabis Capital Conference being held February 25-26, 2021. The conference will feature an interactive forum of live presentations from top CEOs, investors, and leaders in the cannabis sector.
Item 9 Labs Presentation at Benzinga Cannabis Capital Conference
- DATE: Thursday, February 25, 2021
- TIME: 11:30 AM Eastern Time
Bowden will provide an overview of the Company, including its award-winning products, the ongoing operations expansion and other key initiatives, as well as the growth opportunities resulting from the favorable regulatory environment. He also plans to speak in-depth on why franchising is the growth vehicle that will propel the ca